Resources/MoCRA Compliance Checklist for Cosmetic Manufacturers
MoCRA Compliance Checklist for Cosmetic Manufacturers
Disclaimer: The information provided in this guide is for educational and regulatory context purposes only and does not constitute formal legal advice. Compliance requirements can vary based on formulation, regional authority updates, and specific product claims. Consult a certified regulatory affairs professional or specialized legal counsel for official filings.
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents a fundamental shift in the regulatory landscape for cosmetics marketed in the United States, moving towards a more proactive oversight model by the US Food and Drug Administration (FDA). Cosmetic manufacturers and brand owners must implement new requirements concerning facility registration, product listing, safety substantiation, and adverse event reporting to maintain market access.
Key MoCRA Compliance Requirements
MoCRA establishes several critical mandates that directly impact how cosmetic products are developed, manufactured, and marketed in the US. These requirements aim to enhance product safety and provide the FDA with greater visibility into the cosmetic industry.
- Mandatory Facility Registration for all cosmetic manufacturing and processing establishments.
- Mandatory Product Listing for all cosmetic products marketed in the US.
- Requirement for adequate Safety Substantiation for all cosmetic products.
- Mandatory Adverse Event Reporting and recordkeeping.
- Compliance with Good Manufacturing Practices (GMP) as established by the FDA.
- Designation of a Responsible Person for each cosmetic product.
- New Labeling Requirements, including contact information and allergen disclosure.
Facility Registration and Product Listing
Under MoCRA, all facilities involved in the manufacturing or processing of cosmetic products for distribution in the US must register with the FDA. This registration is subject to biennial renewal. Similarly, every cosmetic product marketed in the US must be listed with the FDA, with annual updates required. These listings must include specific information about the product, its ingredients, and the responsible person.
- **Facility Registration:** Required for all domestic and foreign facilities manufacturing or processing cosmetics for the US market. Exemptions apply for certain small businesses.
- **Product Listing:** The Responsible Person must submit a product listing for each cosmetic product, including the facility registration number where the product was manufactured, a list of ingredients, and the product category.
- **Updates:** Both facility registrations and product listings require regular updates to ensure accuracy and compliance with specified deadlines.
Safety Substantiation and Adverse Event Reporting
MoCRA explicitly mandates that the Responsible Person for a cosmetic product must ensure and maintain records demonstrating adequate safety substantiation for that product. This means having scientific evidence to support the safety of the product for its intended use. Furthermore, the Responsible Person is now required to report serious adverse events associated with their products to the FDA within a specified timeframe and maintain records of all adverse events for a defined period.
- **Safety Substantiation:** Requires scientific evidence to support the safety of the cosmetic product for its intended use. The specific nature and extent of this evidence are not prescribed but must be adequate.
- **Serious Adverse Event Reporting:** The Responsible Person must report serious adverse events to the FDA within a specified number of business days after receiving the report.
- **Adverse Event Recordkeeping:** All adverse event reports, serious or otherwise, must be maintained for a specified number of years.
Responsible Person, GMP, and Labeling
MoCRA defines a 'Responsible Person' as the manufacturer, packer, or distributor of a cosmetic product whose name appears on the product label. This entity bears primary responsibility for many of MoCRA's requirements. The Act also grants the FDA authority to establish Good Manufacturing Practices (GMP) for cosmetic facilities, which will standardize manufacturing processes. New labeling requirements include providing a domestic contact address or phone number for adverse event reporting and identifying certain fragrance allergens.
To navigate the specific deadlines, data requirements for product listings, and the precise scope of GMPs and labeling mandates under MoCRA, leverage The Molecule Lab's compliance engine. Our platform provides up-to-date regulatory intelligence, allowing you to verify the current requirements for facility registration, product listing, and other MoCRA obligations for your specific product portfolio. Access detailed guidance and ensure your operations align with the latest FDA regulations through your workspace or by using our public-search tools.
This content was generated by AI. Always verify the information before use.